NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST

Ratings NorthWest Healthcare Properties Real Estate Investment Trust

Equities

NWH.UN

CA6674951059

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
5.05 ^CAD	-1.75%		-1.75%	-2.13%

May. 27	BMO Lifts Northwest Healthcare REIT Target to $5.25, Maintains Market Perform, After Q1	MT
May. 16	NorthWest Healthcare Properties REIT Price Target Raised, Rating Maintained at National Bank	MT

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The company is one of the best yield companies with high dividend expectations.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company has insufficient levels of profitability.
The company is highly valued given the cash flows generated by its activity.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST	-2.13%	927M	-	C+
WELLTOWER INC.	+11.82%	60.31B		A-
HEALTHPEAK PROPERTIES, INC.	-4.49%	13.44B		A
OMEGA HEALTHCARE INVESTORS, INC.	+1.50%	7.78B		B
HEALTHCARE REALTY TRUST INCORPORATED	-9.17%	5.92B		B-
CARETRUST REIT, INC.	+12.65%	3.61B		C-
SABRA HEALTH CARE REIT, INC.	0.00%	3.34B		C+
AEDIFICA SA	-5.97%	3.07B		B+
MEDICAL PROPERTIES TRUST, INC.	+4.07%	3.03B		C
NATIONAL HEALTH INVESTORS, INC.	+15.99%	2.82B		C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes